Triazole derivatives for treating alzheimer'S disease and related conditions
US8242150B2 · kind B2 · utility
11Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 9, 2008 |
| Grant date | Aug 14, 2012 |
| Priority date | — |
| Expiry date | Aug 20, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds of formula I: Selectively attenuate production of Aβ(1-42) and hence find use in treatment or prevention of diseases associated with deposition of Aβ in the brain, in particular Alzheimer's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.